NCT06613633 2025-04-20
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC
Fudan University
Completed
Clinical Trials
3 trialsNCT06352502 2024-04-08
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
Tang-Du Hospital
Recruiting
NCT06117644 2023-11-07
The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not yet recruiting